Dr Vivek Baliga – The role of inflammation in pathogenesis of hypertension

Article by Dr Vivek Baliga This is a nine-year repeated measures data analysis prospective cohort study that was presented at the American Heart Association scientific sessions 2016. The underlying hypothesis for the study was that inflammation affects the development of hypertension through changes in the blood vessel or in renal pathophysiology. The study was a […]

Dr Vivek Baliga – What is the optimum blood pressure target in patients with acute myocardial infarction

Article by Dr Vivek Baliga Recently, a paper was presented at the American Heart Association scientific Sessions in New Orleans that discussed optimal blood pressure target in patients in acute myocardial infarction. The aim of the study was to analyse what the optimal systolic and diastolic BP targets must be in patients who suffer from […]

CCB in Hypertension – Presentation by Dr Vivek Baliga

Calcium channel blockers are commonly used drugs in the treatment of hypertension. They are effective in treating early hypertension though there are some concerns about edema. Here, Dr Vivek Baliga discusses the role of newer calcium channel blockers in the treatment of hypertension. Calcium Channel Blockers in Hypertension from Dr Vivek Baliga Recommended reading Use […]

Vitamin D Levels and CIMT – Paper review Dr Vivek Baliga

Childhood 25-OH Vitamin D Levels and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study J Clin Endocrinol Metab doi: 10.1210/jc.2014-3944 Paper review by Dr Vivek Baliga, Internal Medicine, Baliga Diagnostics Preamble ¡¤         There is increasing interest in the association between vitamin D and atherosclerotic disease ¡¤         Low levels of vitamin D […]